Dr. Remo Moomiaie-Qajar
President and CEO, Cytonus Therapeutics Inc.
About: Moomiaie-Qajar founded Cytonus Therapentics in 2018 to develop next-generation medicines to treat rare cancers and inflammatory diseases. He also is the founder of Clarify Medical, which has developed a home light therapy system for dermatologic disorders such as psoriasis. He also is a member of the Ohio Tech Angel Fund IV. Moomiaie-Qajar received his medical degree from the University of Szeged in Hungary. He is married and lives in German Village with a German short-haired pointer.
As Columbus continues to evolve, it will need to diversify its talent base to compete with other emerging hubs of technology.
Outside of work: Moomiaie-Qajar is president of Chantal Paydar Charities, a nonprofit focused on peace and social justice worldwide. He’s also a donor to the American Heart Association and the Mount Carmel Foundation.
What does Columbus need to thrive? As Columbus continues to evolve, it will need to diversify its talent base to compete with other emerging hubs of technology. Currently, the startup environment is very much driven by consumer goods and IT. The underutilized infrastructure of healthcare in Columbus is where the most value can be created and attract more talent to Columbus.
Moomiaie-Qajar’s idea: Given the current state our city, state and country is in with the (pandemic), there are many people who are unemployed or with job uncertainty in their futures. They are home and have anxieties about what their financial prospects will look like post-Covid-19. As a group of diverse community leaders, I believe a monthly or bi-monthly webinar series could be organized to help the community through this time. Topics centered around entrepreneurship can be taught by business leaders and entrepreneurs who can also provide mentoring. … Friends in various financial situations have recently, more frequently, reached out to me to guide them through a new venture. The common denominator in their desire to go out on their own points to the serious doubts they harbor about the nature of their industry and job status in the near future.